Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study

by GADALETA-CALDAROLA, GENNARO, INFUSINO, STEFANIA, GALISE, IDA, RANIERI, GIROLAMO, VINCIARELLI, GIANLUCA, FAZIO, VITO, DIVELLA, ROSA, DANIELE, ANTONELLA, FILIPPELLI, GIANFRANCO, GADALETA, COSMO DAMIANO
Published 2014

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer....

by Vici, Patrizia, Colucci, Giuseppe, Giotta, Francesco, Sergi, Domenico, Filippelli, Gianfranco, Perri, Pasquale, Botti, Claudio, Vizza, Enrico, Carpino, Armando, Pizzuti, Laura, Latorre, Agnese, Giannarelli, Diana, Lopez, Massimo, Di Lauro, Luigi
Published 2011

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

by Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista
Published 2013

Tumour‐associated macrophages correlate with microvascular bed extension in colorectal cancer patients

by Marech, Ilaria, Ammendola, Michele, Sacco, Rosario, Sammarco, Giuseppe, Zuccalà, Valeria, Zizzo, Nicola, Leporini, Christian, Luposella, Maria, Patruno, Rosa, Filippelli, Gianfranco, Russo, Emilio, Porcelli, Mariangela, Gadaleta, Cosmo Damiano, De Sarro, Giovambattista, Ranieri, Girolamo
Published in J Cell Mol Med (2016)

Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer

by Formica, Vincenzo, Ionta, Maria Teresa, Massidda, Bruno, Vessia, Giacomo, Maiorino, Luigi, Casaretti, Rossana, Natale, Donato, Barberis, Giuseppe, Filippelli, Gianfranco, Greco, Ettore, Blasi, Livio, Mancarella, Sergio, Russo, Anna, Barbato, Enrico, Lullo, Liberato Di, Roselli, Mario
Published in Oncotarget (2017)

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

by Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Published in Tumori (2019)

Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study

by Fabi, Alessandra, De Laurentiis, Michelino, Caruso, Michele, Valle, Enrichetta, Moscetti, Luca, Santini, Daniele, Cannita, Katia, Carbognin, Luisa, Ciccarese, Mariangela, Rossello, Rosalba, Arpino, Grazia, Leonardi, Vita, Montemurro, Filippo, La Verde, Nicla, Generali, Daniele, Zambelli, Alberto, Scandurra, Giuseppa, Russillo, Michelangelo, Paris, Ida, D'Ottavio, Anna Maria, Filippelli, Gianfranco, Giampaglia, Marianna, Stani, Simonetta, Fabbri, Agnese, Alesini, Daniele, Cianniello, Daniela, Giannarelli, Diana, Cognetti, Francesco
Published in Oncotarget (2017)